Hepion Pharmaceuticals
HEPA
#10815
Rank
HK$0.11 B
Marketcap
HK$0.93
Share price
3.22%
Change (1 day)
70.78%
Change (1 year)

EPS for Hepion Pharmaceuticals (HEPA)

EPS in 2026 (TTM): -HK$2.19

According to Hepion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$2.19. In 2025 the company made an earnings per share (EPS) of -HK$6.90 an increase over its 2024 EPS that were of -HK$841.51.

EPS history for Hepion Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$2.19-68.2%
2025-HK$6.90-99.18%
2024-HK$841.51-82.58%
2023-HK$4,8293.54%
2022-HK$4,66426.6%
2021-HK$3,684-77.62%
2020-HK$16,462-65.63%
2019-HK$47,896-91.91%
2018-HK$592,090-31.52%
2017-HK$864,663-63.01%
2016-HK$2,337,730-47.59%
2015-HK$4,460,640244.82%
2014-HK$1,293,6253875983.57%
2013-HK$33.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58 382.14%๐Ÿ‡บ๐Ÿ‡ธ USA